Journal of Pharmaceutical Investigation
- 제30권3호
- /
- Pages.179-189
- /
- 2000
- /
- 2093-5552(pISSN)
- /
- 2093-6214(eISSN)
말산클레보프리드 서방성 제제의 제조 및 약물동태학적 평가
Formulation and Pharmacokinetic Evaluation of Sustained Release Preparation Containing Clebopride Malate
- 류해원 (보령제약(주)중앙연구소) ;
- 이주한 (보령제약(주)중앙연구소) ;
-
지용하
(보령제약(주)중앙연구소) ;
- 한양희 (보령제약(주)중앙연구소) ;
- 단현광 (보령제약(주)중앙연구소) ;
- 이규흥 (보령제약(주)중앙연구소) ;
- 김상린 (보령제약(주)중앙연구소) ;
- 전승윤 (중앙대학교 약학대학) ;
-
최영욱
(중앙대학교 약학대학)
- Ryou, Hae-Won (Boryung Pharmaceutical Co., Ltd.) ;
- Lee, Joo-Han (Boryung Pharmaceutical Co., Ltd.) ;
-
Chi, Yong-Ha
(Boryung Pharmaceutical Co., Ltd.) ;
- Hahn, Yang-Hee (Boryung Pharmaceutical Co., Ltd.) ;
- Tan, Hyun-Kwang (Boryung Pharmaceutical Co., Ltd.) ;
- Lee, Kyu-Heung (Boryung Pharmaceutical Co., Ltd.) ;
- Kim, Sang-Lin (Boryung Pharmaceutical Co., Ltd.) ;
- Jeon, Seung-Yoon (College of Pharmacy, Chung-Ang University) ;
-
Choi, Young-Wook
(College of Pharmacy, Chung-Ang University)
- 발행 : 2000.09.20
초록
Clebopride malate(Cm) is a new benzamide drug which has a potent central antidopaminergic activity possessing antiemetic and anxiolytic properties. A purpose of this study was to assess the feasibility of formulating sustained release preparation by dispersing a drug in hydrophilic polymeric matrices and double layered tablets(DLT), using HPMC, carbopol, PEO, PVP/VA and other polymers as a rate controlling barrier. The matrix and DLT showed optimum dissolution pattern up to 8 hours and the contents of polymer were optimized at 30% level in this preparation. After an oral administration in beagle dog, Cm concentration was determined by use of GC-ECD and pharmacokinetic parameters were calculated by Vallner's method. The AUC of DLT showed similar results and the duration of action was increased 55% compared to that of regular release dosage form. The calculated absorption rate effectiveness(ARE) and controlled release effectiveness(CRE) for DLT increased 50% compared to that of matrix, the overall effectiveness(E) of this product appears to be about 70%. in vivo effectiveness test, DLT showed significant differences from control on antiemetic action of Cm. In consequence, it was possible to conclude that double layered tablet might be a good candidate for the sustained release dosage forms.
키워드